WuXi AppTec (HKG:2359, SHA:603259) recorded an 89% rise in attributable profit in the first quarter to 3.67 billion yuan from 1.94 billion yuan a year prior, a Monday filing with the Hong Kong bourse said.
Earnings per share stood at 1.28 yuan in the three months, up from 0.66 yuan in the year-ago period.
The drug research and development company's revenue rose 21% to 9.65 billion yuan from 7.98 billion yuan previously.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.